gdc

Lymphoma

7-Year-Old Lynden Raises Money for Cancer Research While Fighting Lymphoma
LymphomaPediatric Cancer
A year before Lynden was diagnosed with cancer, she cut off her hair and donated it to help kids with cancer. After her diagnosis, she launched a new project. She is just getting started, but so far she has raised more than $65,000 for pediatric cancer research.
Spreading Fun and Games
Humor & CancerPatient StoriesLymphoma
Rex Jones found a unique way to keep his mood upbeat and spread good vibes to others during his chemotherapy for lymphoma.
Silver Linings
Patient StoriesLymphoma
Stacey Roselle looked for the “silver linings” when a diagnosis of non-Hodgkin lymphoma brought her face-to-face with unexpected reactions to her illness.
First Love Yourself: Picking Up the Pieces
Patient StoriesLymphoma
When 24-year-old Mia Brister was diagnosed with Hodgkin lymphoma, it was as if her whole world had shattered. She had to learn to be kind with herself to put her life together again.
Brukinsa FDA Approved for Mantle-Cell Lymphoma
LymphomaFDA Approvals, News & Updates
In November 2019, the FDA approved the second Bruton tyrosine kinase inhibitor for the treatment of adults with mantle-cell lymphoma (a type of non-Hodgkin lymphoma) who have received at least 1 previous therapy.
Working with Your Treatment Team to Decide on the Best Options for You
LeukemiaLymphomaMultiple Myeloma
People who are diagnosed with blood cancer need to learn enough about it without being overwhelmed, and to take part in their treatment decisions. Communicate important personal information to your care team.
Polivy a New Targeted Immunotherapy Approved for Patients with B-Cell Lymphoma
FDA Approvals, News & UpdatesLymphomaNewsworthy
In June 2019, the FDA approved a new type of immunotherapy called Polivy, for use in combination with other drugs, in patients with previously treated diffuse large B-cell lymphoma (DLBCL), offering new options for patients whose cancer has returned.
Cancer and Me
LymphomaPatient Stories
Brigid Wallace contemplates the choices she made when living in the “new normal” after her cancer diagnosis. She describes the struggles and personal victories that tested her faith and strength after she learned she had non-Hodgkin lymphoma.
FDA Calls Attention to Risk Associated with Breast Implants: Anaplastic Large-Cell Lymphoma
Breast CancerLymphomaSurvivorship
In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here.
Page 3 of 7
Results 21 - 30 of 62

Subscribe to CONQUER: the patient voice

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests